SATISH SHANBHAG, MD

BIOGRAPHY

Dr. Satish Shanbhag is board certified in hematology and oncology and practices at our Fleming Island location. Born in India, Dr. Shanbhag obtained his medical degree from Bangalore Medical College in Bangalore, India.

Like most, Dr. Shanbhag has had personal experiences with cancer which pushed him to become an oncologist. “I have been on the other side and seen what cancer looks like from the viewpoint of a son and grandson” Dr. Shanbhag says. Because of this, he views and treats every patient like he would a close family member.  “It is critical that discoveries in cancer care in the last decade, such as immunotherapy and targeted therapy reach every patient who could benefit and make a real impact on their lives”.

A believer in patient-centered care and shared decision making, Dr. Shanbhag is proud to work at Cancer Specialists of North Florida, saying “I am very privileged to be part of a team of healthcare specialists who work night and day to improve our patient’s lives while running a robust research and education program”. He believes that the core mission of oncologists is to help patients live longer and healthier lives; “helping patients transition into long term survivorship is a special feeling – we should pray and fight for more of these moments”.

Before joining Cancer Specialists of North Florida, Dr. Shanbhag was Associate professor of oncology and Medical Director of the cancer center at the famed Johns Hopkins University in Baltimore, MD. He is nationally recognized for his expertise, particularly for blood related cancers and conditions and has numerous articles, presentations at conferences and book chapters to his name. He has also won numerous regional and national awards for clinical excellence and teaching.

An outdoor and fitness enthusiast, Dr. Shanbhag and his wife and two daughters enjoy visiting national parks, biking, and hiking.

Curriculum Vitae

BOARD CERTIFICATIONS

Medical Oncology
Hematology

PROFESSIONAL ASSOCIATIONS

American Society of Clinical Oncology
American Society of Hematology
American College of Physicians

FELLOWSHIP

Temple University Hospital and Fox Chase Cancer Center
Hematology & Oncology

RESIDENCY

University of Alabama at Birmingham
Internal Medicine

EDUCATION

Bangalore Medical College
Doctor of Medicine
University of Alabama at Birmingham
Master of Public Health in Healthcare Organization & Policy

HONORS & AWARDS

2019
Best Consulting Physician, The Office of Johns Hopkins Physicians Clinical Excellence Awards
2016
American Society of Hematology Medical Educators Institute Award
2015
Fellow of the American College of Physicians
2015
Samuel Asper Award for Excellence in Internal Medicine
2014
Lisa J. Heiser Award for Educational Excellence awarded by The Johns Hopkins Institute
2013
Faculty Teaching Excellence Award
2013
Member, The Miller-Coulson Academy of Clinical Excellence at Johns Hopkins
2012
Chairman’s Award, Department of Medicine, Johns Hopkins Bayview Medical Center

PUBLICATIONS

Journal of the American Society for Blood and Marrow Transplantation
'Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors' Biology of blood and marrow transplantation
Blood Journal
Modified Ham test for atypical hemolytic uremic syndrome.
Open Forum Infect Diseases
Histoplasmosis-induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.
Journal of Clinical Oncology
Outcomes of Nonmyeloablative, HLA-Haploidentical BMT with High-Dose Posttransplantation of Cyclophosphamide in Older Adults
Biology of Blood & Marrow Transplantation
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
Biology of Blood & Marrow Transplantation
Shortened-duration tacrolimus after nonmyeloablative, HLA- haploidentical BMT.
Cancer Chemotherapy and Pharmacology
Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.
Biology of Blood and Marrow Transplantation
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors
Journal of the National Comprehensive Cancer Network
NCCN Guidelines Insights: T-Cell Lymphomas
Medicine
A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis
Leukemia & Lymphoma
R-CHOP without Radiation in Frontline Management of Primary Mediastinal B-cell Lymphoma
European Journal of Cancer
Brentuximab Vedotin for Frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?
Mayo Clinic Proceedings
“The 700 dollar vitamin”: The Epidemic of Synthetic Cannabinoid Associated Coagulopathy. A case study of excessive generic drug prices in the American health care system
Journal of the NCCN
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events
American Journal of Hematology
Ibrutinib-associated Hemophagocytic Lymphohistiocytosis: a case series from Johns Hopkins
Medicine
Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: case series and management recommendations
Blood
Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP
Journal of Clinical Oncology
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II
Biology of Blood and Marrow Transplantation
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplant Cyclophosphamide in Chronic Lymphocytic Leukemia